Sign Out
Clinically significant adverse reactions: Shock, anaphylactoid reaction: since shock anaphylactoid reaction may occur, patients should be carefully observed. If any symptoms such as erythema, rash dyspnoea, decreased blood pressure, and eyelid oedema, etc. are observed, administration should be discontinued and appropriate measures should be taken.
Other adverse reactions: If the following adverse reactions are observed, appropriate measures such as discontinuing administration should be taken: Hypersensitivity: Blepharitis (eyelid redness/oedema, etc.), eyelid dermatitis, itching, rash, urticaria.
Ophthalmic: irritation, corneal lesion such as keratitis superficial diffuse, conjunctivitis (conjunctival injection/oedema, etc.)
View ADR Reporting Link
Lanjutkan dengan Google